New highly active taxoids from 9β-dihydrobaccatin-9,10-acetals. Part 3

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 2, 2003, Pages 185-190

  Takeda, Yasuyuki ^a   Yoshino, Toshiharu ^a   Uoto, Kouichi ^a   Chiba, Jun ^a   Ishiyama, Takashi ^a   Iwahana, Michio ^a   Jimbo, Takeshi ^a   Tanaka, Noriko ^a   Terasawa, Hirofumi ^a   Soga, Tsunehiko ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 DEOXY 9 BETA DIHYDRO 9,10 O ACETAL TAXANE; 9 BETA DIHYDROBACCATIN 9,10 ACETAL; ACETAL DERIVATIVE; DOCETAXEL; GLYCOPROTEIN P; PACLITAXEL; TAXANE DERIVATIVE; TAXOID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; DRUG CYTOTOXICITY; DRUG SYNTHESIS; IN VIVO STUDY; MELANOMA B16; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CONFORMATION; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL MELANOMA; HUMAN; MOUSE; SOLUBILITY; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SURVIVAL; CRYSTALLOGRAPHY, X-RAY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDICATORS AND REAGENTS; MELANOMA, EXPERIMENTAL; MICE; MOLECULAR CONFORMATION; NEOPLASM TRANSPLANTATION; PACLITAXEL; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 18744382450     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00891-0     Document Type: Article

References (18)

1. Wani M.C., Taylor H.L., Wall M.E., Coggon P., McPhail A.T. J. Am. Chem. Soc. 93:1971;2325.
2. Guéritte-Voegelein F., Guénard D., Lavelle F., Le Goff M.-T., Mangatal L., Potier P. J. Med. Chem. 34:1991;992.
3. Vyas D.M., Wong H., Croswell A.R., Casazza A.M., Knipe J.O., Mamber S.W., Doyle T.W. Bioorg. Med. Chem. Lett. 3:1993;1357.
4. (a) Uoto K., Takenoshita H., Yoshino T., Hirota Y., Ando S., Mitsui I., Terasawa H., Soga T. Chem. Pharm. Bull. 46:1998;770.
5. (b) Iimura S., Ohsuki S., Chiba J., Uoto K., Iwahana M., Terasawa H., Soga T. Heterocycles. 53:2000;2719.
6. Ishiyama T., Iimura S., Yoshino T., Chiba J., Uoto K., Terasawa H., Soga T. Bioorg. Med. Chem. Lett. 12:2002;2815.
7. Kant J., Schwartz W.S., Fairchild C., Gao Q., Huang S., Long B.H., Kadow J.F., Langley D.R., Farina V., Vyas D. Tetrahedron Lett. 37:1996;6495.
8. Ojima I., Habus I., Zhao M., Zucco M., Park Y.H., Sun C.M., Brigaud T. Tetrahedron. 48:1992;6985.
9. 3).
10. Ojima I., Sun C.M., Zucco M., Park Y.H., Duclos O., Kuduk S. Tetrahedron Lett. 34:1993;4149.
11. 3).
12. 3).
13. Georg G.I., Harrima G.C.B., Hepperle M., Himes R.H. Bioorg. Med. Chem. Lett. 4:1994;1381.
14. Hart D.J., Kanai K., Thomas D.G., Yang T.-K. J. Org. Chem. 48:1983;289.
15. 3).
16. 3. The final R value was 0.061.
17. PC-6/VCR29-9: PC-6 cell line, which is resistant to Vincristine®. PC-6/VP1-1: PC-6 cell line, which is resistant to VP-16 (Etoposide®).
18. Poste G., Doll J., Hart I.R., Fidler I.J. Cancer Res. 40:1980;1636.